Breaking News Instant updates and real-time market news.

2021-03-04 16:09:07 SOLY Soliton $12.20 / -0.94 (-7.15%) 16:09 03/04/21 03/04 16:09 03/04/21 16:09	Soliton reports Q4 EPS (22c), consensus (23c) Brad Hauser, Soliton's President and CEO, commented, "Despite the challenges presented by 2020, this was a transformative year for the Company, which has positioned us for long-term success and the upcoming initial launch of our RAP device in cellulite reduction and tattoo removal during the second quarter of 2021. We are extremely encouraged by the progress we made in preparation for our upcoming initial launch, as we received FDA 510(k) clearance for the RAP device in cellulite, bolstered our sales team by hiring aesthetic veteran Sean Shapiro as VP of Sales, and initiated the transition to manufacturing with our manufacturing partner. I am very excited to share that we have selected RESONIC as the brand name for our RAP device, which we believe captures our technology's foundation in sound and will provide a true identity for our technology with customers and consumers. While ensuring a successful initial launch remains our key priority, we are also encouraged by the promise our RAP device has demonstrated in selected adjacent indications, such as fibrotic scars and liver fibrosis. 2021 will be a pivotal year for the company as we transition to a commercial company. We look forward to launching our RESONIC device in cellulite reduction and tattoo removal and driving its clinical progress across adjacent indications with our goal of delivering shareholder value."	04 Mar 15 Mar 16 Mar 26 Jun
SOLY Soliton $12.20 / -0.94 (-7.15%) 02/08/21 Maxim Soliton price target raised to $25 from $22 at Maxim 02/02/21 Cantor Fitzgerald Soliton price target raised to $20 from $12 at Cantor Fitzgerald 07/15/20 Cantor Fitzgerald Soliton initiated with an Overweight at Cantor Fitzgerald 06/16/20 Roth Capital Soliton price target raised to $16 from $14 at Roth Capital

2021-03-04 16:09:07

SOLY

Soliton

$12.20 / -0.94 (-7.15%)

16:09

03/04/21

03/04

16:09

03/04/21

16:09

Soliton reports Q4 EPS (22c), consensus (23c)

Brad Hauser, Soliton's President and CEO, commented, "Despite the challenges presented by 2020, this was a transformative year for the Company, which has positioned us for long-term success and the upcoming initial launch of our RAP device in cellulite reduction and tattoo removal during the second quarter of 2021. We are extremely encouraged by the progress we made in preparation for our upcoming initial launch, as we received FDA 510(k) clearance for the RAP device in cellulite, bolstered our sales team by hiring aesthetic veteran Sean Shapiro as VP of Sales, and initiated the transition to manufacturing with our manufacturing partner. I am very excited to share that we have selected RESONIC as the brand name for our RAP device, which we believe captures our technology's foundation in sound and will provide a true identity for our technology with customers and consumers. While ensuring a successful initial launch remains our key priority, we are also encouraged by the promise our RAP device has demonstrated in selected adjacent indications, such as fibrotic scars and liver fibrosis. 2021 will be a pivotal year for the company as we transition to a commercial company. We look forward to launching our RESONIC device in cellulite reduction and tattoo removal and driving its clinical progress across adjacent indications with our goal of delivering shareholder value."

04
Mar
15
Mar
16
Mar

26
Jun

SOLY Soliton

$12.20 / -0.94 (-7.15%)

02/08/21 Maxim: Soliton price target raised to $25 from $22 at Maxim

02/02/21 Cantor Fitzgerald: Soliton price target raised to $20 from $12 at Cantor Fitzgerald

07/15/20 Cantor Fitzgerald: Soliton initiated with an Overweight at Cantor Fitzgerald

06/16/20 Roth Capital: Soliton price target raised to $16 from $14 at Roth Capital

TODAY'S FREE FLY STORIES

Recommendations	LafargeHolcim price target raised to CHF 61.50 from CHF 57 at UBS » 15:12 04/13/21 04/13 15:12 04/13/21 15:12 HCMLY LafargeHolcim $12.32 / -0.02 (-0.16%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals HCMLY LafargeHolcim $12.32 / -0.02 (-0.16%) 02/01/21 Cemex to divest certain assets in France to LafargeHolcim HCMLY LafargeHolcim $12.32 / -0.02 (-0.16%) 04/09/21 Barclays LafargeHolcim price target raised to CHF 60 from CHF 57 at Barclays 03/22/21 JPMorgan LafargeHolcim price target raised to CHF 60 from CHF 57 at JPMorgan 03/04/21 Berenberg LafargeHolcim price target raised to CHF 52 from CHF 51 at Berenberg 03/01/21 Credit Suisse LafargeHolcim price target raised to CHF 67 from CHF 64 at Credit Suisse HCMLY LafargeHolcim $12.32 / -0.02 (-0.16%) 01/04/21 LafargeHolcim in talks to acquire Bridgestone unit, Bloomberg says
Recommendations	Epiroc price target raised to SEK 200 from SEK 159 at UBS » 15:12 04/13/21 04/13 15:12 04/13/21 15:12 EPOKY Epiroc $23.81 / -0.37 (-1.53%) UBS analyst Guillermo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EPOKY Epiroc $23.81 / -0.37 (-1.53%) 12/22/20 Dundee Precious Metals announces sale of MineRP to Epiroc Canada EPOKY Epiroc $23.81 / -0.37 (-1.53%) 05:18 Today Pareto Epiroc downgraded to Sell from Hold at Pareto 04/12/21 Societe Generale Epiroc downgraded to Hold on valuation at Societe Generale 04/12/21 Societe Generale Epiroc downgraded to Hold from Buy at Societe Generale 04/06/21 Barclays Epiroc price target raised to SEK 185 from SEK 165 at Barclays
Hot Stocks	Microsoft issues patch for on-premise Exchange Servers after NSA tip » 15:09 04/13/21 04/13 15:09 04/13/21 15:09 MSFT Microsoft $258.29 / +2.28 (+0.89%) In a post to the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT Microsoft $258.29 / +2.28 (+0.89%) 04/12/21 Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash 04/12/21 Unisys names Dwayne Allen as Chief Technology Officer MSFT Microsoft $258.29 / +2.28 (+0.89%) 09:11 Today Morgan Stanley Morgan Stanley says Microsoft 'uniquely positioned' for synergies with Nuance 08:43 Today Craig-Hallum Nuance downgraded to Hold from Buy at Craig-Hallum 08:02 Today Wedbush Nuance downgraded to Neutral at Wedbush on Microsoft deal 07:37 Today Argus Microsoft price target raised to $300 from $275 at Argus MSFT Microsoft $258.29 / +2.28 (+0.89%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B MSFT Microsoft $258.29 / +2.28 (+0.89%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says 04/09/21 Hackers scraped data of 500M LinkedIn users, Insider reports 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says 04/01/21 LinkedIn testing Clubhouse competitor, Business Insider reports MSFT Microsoft $258.29 / +2.28 (+0.89%) 12:34 Today Game On: GameStop may be looking for new CEO 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 05/24/21 Global Technology, Media & Communications Virtual Conference MSFT Microsoft $258.29 / +2.28 (+0.89%) 04/06/21 Microsoft call buyer realizes 130% same-day gains 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th
Recommendations	Atlas Copco price target raised to SEK 535 from SEK 468 at UBS » 15:08 04/13/21 04/13 15:08 04/13/21 15:08 ATLKY Atlas Copco $63.84 / -1.5 (-2.30%) UBS analyst Guillermo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research ATLKY Atlas Copco $63.84 / -1.5 (-2.30%) 12/21/20 Perceptron completes merger with Atlas Copco ATLKY Atlas Copco $63.84 / -1.5 (-2.30%) 04/06/21 Barclays Atlas Copco price target raised to SEK 500 from SEK 420 at Barclays 03/24/21 JPMorgan Atlas Copco price target raised to SEK 480 from SEK 460 at JPMorgan 02/05/21 Berenberg Atlas Copco price target raised to SEK 405 from SEK 390 at Berenberg 02/01/21 JPMorgan Atlas Copco price target raised to SEK 460 from SEK 440 at JPMorgan
Recommendations	Andritz price target raised to EUR 52 from EUR 50 at UBS » 15:08 04/13/21 04/13 15:08 04/13/21 15:08 ADRZY Andritz $10.01 / + (+0.00%) UBS analyst Sven Weier… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ADRZY Andritz $10.01 / + (+0.00%) 03/05/21 Deutsche Bank Andritz price target raised to EUR 48 from EUR 46 at Deutsche Bank 03/04/21 UBS Andritz price target raised to EUR 50 from EUR 46 at UBS 03/04/21 Morgan Stanley Andritz price target raised to EUR 40 from EUR 38 at Morgan Stanley 02/11/21 Deutsche Bank Andritz price target raised to EUR 46 from EUR 38 at Deutsche Bank

Recommendations	Alfa Laval price target raised to SEK 261 from SEK 238 at UBS » 15:08 04/13/21 04/13 15:08 04/13/21 15:08 ALFVY Alfa Laval $31.70 / -0.05 (-0.16%) UBS analyst Sven Weier… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research ALFVY Alfa Laval $31.70 / -0.05 (-0.16%) 10/20/20 Alfa Laval awarded SEK 130M order to supply processing line to HollyFrontier ALFVY Alfa Laval $31.70 / -0.05 (-0.16%) 04/07/21 Morgan Stanley Alfa Laval price target raised to SEK 248 from SEK 219 at Morgan Stanley 03/31/21 Danske Bank Alfa Laval downgraded to Hold from Buy at Danske Bank 03/01/21 JPMorgan Alfa Laval price target raised to SEK 245 from SEK 205 at JPMorgan 02/10/21 Barclays Alfa Laval upgraded to Equal Weight from Underweight at Barclays
Hot Stocks	AmpliTech Group announces developmental order from Amplify My Probe » 15:07 04/13/21 04/13 15:07 04/13/21 15:07 AMPG AmpliTech Group $8.75 / -0.25 (-2.78%) AmpliTech Group announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News AMPG AmpliTech Group $8.75 / -0.25 (-2.78%) 04/06/21 AmpliTech Group receives order from major defense contractor
Conference/Events	Federal Reserve Bank of Atlanta president participates in virtual event » 15:05 04/13/21 04/13 15:05 04/13/21 15:05 Atlanta Federal Reserve… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Options	Mesabi Trust options imply 4.0% move in share price post-earnings » 15:04 04/13/21 04/13 15:04 04/13/21 15:04 MSB Mesabi Trust $35.23 / +2.65 (+8.13%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Teleperformance price target raised to EUR 370 from EUR 350 at Morgan Stanley » 15:03 04/13/21 04/13 15:03 04/13/21 15:03 TLPFY Teleperformance $194.94 / +4.2 (+2.20%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLPFY Teleperformance $194.94 / +4.2 (+2.20%) 14:29 Today JPMorgan Teleperformance price target raised to EUR 370 from EUR 340 at JPMorgan 05:04 Today AlphaValue Teleperformance upgraded to Add from Reduce at AlphaValue 03/17/21 Morgan Stanley Teleperformance price target raised to EUR 350 from EUR 340 at Morgan Stanley 03/01/21 Deutsche Bank Teleperformance price target raised to EUR 355 from EUR 345 at Deutsche Bank

Recommendations	Repsol price target raised to EUR 10.90 from EUR 10 at Morgan Stanley » 15:02 04/13/21 04/13 15:02 04/13/21 15:02 REPYY Repsol $12.15 / +0.04 (+0.33%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research REPYY Repsol $12.15 / +0.04 (+0.33%) 06:56 Today JPMorgan Repsol upgraded to Neutral on balanced risk/reward at JPMorgan 05:13 Today Exane BNP Paribas Repsol downgraded to Underperform from Neutral at Exane BNP Paribas 04/12/21 JPMorgan Repsol upgraded to Neutral from Underweight at JPMorgan 03/12/21 Deutsche Bank Repsol initiated with a Buy at Deutsche Bank
Recommendations	OMV AG price target raised to EUR 49 from EUR 44 at Morgan Stanley » 15:02 04/13/21 04/13 15:02 04/13/21 15:02 OMVKY OMV AG $50.74 / +0.66 (+1.32%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research OMVKY OMV AG $50.74 / +0.66 (+1.32%) 12/15/20 H2Accelerate participants collaborate for hydrogen trucking roll-out OMVKY OMV AG $50.74 / +0.66 (+1.32%) 14:28 Today JPMorgan OMV AG price target raised to EUR 52 from EUR 50 at JPMorgan 03/12/21 Deutsche Bank OMV AG initiated with a Buy at Deutsche Bank 03/03/21 JPMorgan OMV AG price target raised to EUR 50 from EUR 44 at JPMorgan 02/16/21 UBS OMV AG upgraded to Buy from Neutral at UBS
Recommendations	Galp Energia price target raised to EUR 10.50 from EUR 10.20 at Morgan Stanley » 15:02 04/13/21 04/13 15:02 04/13/21 15:02 GLPEY Galp Energia $5.65 / -0.085 (-1.48%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GLPEY Galp Energia $5.65 / -0.085 (-1.48%) 03/05/21 Goldman Sachs Galp Energia upgraded to Buy from Neutral at Goldman Sachs 02/23/21 Credit Suisse Galp Energia price target lowered to EUR 13 from EUR 14 at Credit Suisse 01/21/21 Jefferies Galp Energia initiated with a Hold at Jefferies 01/15/21 JPMorgan Galp Energia price target lowered to EUR 11 from EUR 11.50 at JPMorgan
Recommendations	Covestro price target raised to EUR 67 from EUR 60 at Morgan Stanley » 15:00 04/13/21 04/13 15:00 04/13/21 15:00 COVTY Covestro $33.75 / +0.3 (+0.90%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research COVTY Covestro $33.75 / +0.3 (+0.90%) 03/19/21 UBS Covestro price target raised to EUR 50 from EUR 46 at UBS 03/08/21 Citi Covestro downgraded to Sell from Buy at Citi 02/25/21 Berenberg Covestro price target raised to EUR 65 from EUR 60 at Berenberg 02/25/21 Societe Generale Covestro price target raised to EUR 74 from EUR 65 at Societe Generale
Recommendations	AdaptHealth key leadership remains in place, says RBC Capital » 15:00 04/13/21 04/13 15:00 04/13/21 15:00 AHCO AdaptHealth / + After AdaptHealth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options AHCO AdaptHealth / + 09:50 Today AdaptHealth places co-CEO Luke McGee on unpaid leave 09:49 Today AdaptHealth board: Denmark athorities formally charge co-CEO with tax fraud 01/04/21 AdaptHealth falls 5% to $34.00 per share after equity offering 12/01/20 AdaptHealth, AeroCare combination to operate under AdaptHealth name AHCO AdaptHealth / + 12:14 Today Baird AdaptHealth downgraded to Neutral from Outperform at Baird 11:03 Today Canaccord Charges against McGee not related to AdaptHealth, says Canaccord 10:35 Today Stifel Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook 04/12/21 Baird AdaptHealth price target raised to $49 from $47 at Baird AHCO AdaptHealth / + 03/04/21 AdaptHealth raises FY21 revenue view to $2.18B-$2.35B from $2.05B-$2.2B 03/04/21 AdaptHealth reports Q4 EPS (47c) with charge, consensus 17c 12/01/20 AdaptHealth raises FY21 revenue view to $2.05B-$2.2B from $1.3B-$1.4B 11/04/20 AdaptHealth sees FY21 revenue $1.3B-$1.4B, consensus $1.21B 06 Jan 15 Dec 03 Sep 01 Jul AHCO AdaptHealth / + 12:06 Today Fly Intel: Wall Street's top stories at midday 05/24/21 Global Healthcare Virtual Conference 2021 AHCO AdaptHealth / + 11/25/20 new option listings on November 25th

Recommendations	Telenet price target lowered to EUR 55 from EUR 60 at Deutsche Bank » 15:00 04/13/21 04/13 15:00 04/13/21 15:00 TLGHY Telenet $20.77 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLGHY Telenet $20.77 / + (+0.00%) 12/08/20 JPMorgan Telenet upgraded to Overweight from Neutral at JPMorgan 11/04/20 UBS Telenet price target lowered to EUR 33 from EUR 41.50 at UBS 10/23/20 Barclays Telenet price target raised to EUR 43 from EUR 40 at Barclays 10/15/20 BofA Telenet upgraded to Buy from Underperform at BofA
Recommendations	Ryanair price target lowered to EUR 17.60 from EUR 18.50 at Deutsche Bank » 14:59 04/13/21 04/13 14:59 04/13/21 14:59 RYAAY Ryanair $105.83 / -0.13 (-0.12%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals RYAAY Ryanair $105.83 / -0.13 (-0.12%) 01/27/21 Ryanair selects Plurasight Flow to optimize speed, workflows of engineering team 12/27/20 Fly Intel: Top five weekend stock stories 12/03/20 Boeing confirms order for 75 additional 737 MAX airplanes from Ryanair 12/03/20 Ryanair hopes to take delivery of at least 50 MAX aircraft in 2021 RYAAY Ryanair $105.83 / -0.13 (-0.12%) 04/12/21 HSBC Ryanair downgraded to Hold on U.K. reopening plans at HSBC 04/12/21 HSBC Ryanair downgraded to Hold from Buy at HSBC 04/07/21 AlphaValue Ryanair downgraded to Add from Buy at AlphaValue 03/30/21 Berenberg Ryanair upgraded to Buy from Hold at Berenberg RYAAY Ryanair $105.83 / -0.13 (-0.12%) 03/24/21 Ryanair CEO urges tourists to book foreign vacations, Reuters says 12/26/20 Delta, Southwest among airline stocks that could cruise higher, Barron's says 12/22/20 Germany extends U.K. travel ban to January 6, Sky News reports 12/07/20 IAG dismisses Ryanair comments on British Airways holding, Reuters says
Periodicals	South Africa suspends rollout of Johnson & Johnson vaccine, Bloomberg reports » 14:59 04/13/21 04/13 14:59 04/13/21 14:59 JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) South Africa has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:25 Today Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 07:15 Today J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 09:34 Today Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 09:48 Today CVS Health tells Bloomberg pausing administration of J&J COVID vaccine 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports 04/09/21 J&J in talks for trial in India of COVID-19 vaccine, Business Standard says JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 12:06 Today Fly Intel: Wall Street's top stories at midday 11:12 Today Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 08:58 Today Fly Intel: Pre-market Movers 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/20/21 Johnson & Johnson - JNJ 04/22/21 Johnson & Johnson JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 09:40 Today Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th
Recommendations	Outokumpu price target raised to EUR 5.70 from EUR 4.30 at Deutsche Bank » 14:58 04/13/21 04/13 14:58 04/13/21 14:58 OUTKY Outokumpu $3.07 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research OUTKY Outokumpu $3.07 / + (+0.00%) 05:21 Today AlphaValue Outokumpu upgraded to Reduce from Sell at AlphaValue 03/24/21 Morgan Stanley Outokumpu upgraded to Overweight from Equal Weight at Morgan Stanley 03/22/21 Kepler Cheuvreux Outokumpu upgraded to Buy from Reduce at Kepler Cheuvreux 02/05/21 JPMorgan Outokumpu price target raised to EUR 5.30 from EUR 4.90 at JPMorgan
Recommendations	Swedbank price target raised to SEK 196 from SEK 188 at Deutsche Bank » 14:58 04/13/21 04/13 14:58 04/13/21 14:58 SWDBY Swedbank $18.55 / +0.085 (+0.46%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SWDBY Swedbank $18.55 / +0.085 (+0.46%) 04/12/21 UBS Swedbank price target raised to SEK 175 from SEK 170 at UBS 03/09/21 Barclays Swedbank price target raised to SEK 190 from SEK 172 at Barclays 02/16/21 JPMorgan Swedbank downgraded to Neutral from Overweight at JPMorgan 02/16/21 Deutsche Bank Swedbank downgraded to Hold from Buy at Deutsche Bank

Recommendations	Svenska Handelsbanken price target raised to SEK 118 at Deutsche Bank » 14:57 04/13/21 04/13 14:57 04/13/21 14:57 SVNLY Svenska Handelsbanken $5.64 / +0.035 (+0.62%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SVNLY Svenska Handelsbanken $5.64 / +0.035 (+0.62%) 04/12/21 Barclays Svenska Handelsbanken price target raised to SEK 112 from SEK 105 at Barclays 04/01/21 UBS Svenska Handelsbanken price target raised to SEK 92 from SEK 89 at UBS 03/08/21 Morgan Stanley Svenska Handelsbanken price target raised to SEK 110 at Morgan Stanley 03/04/21 Citi Svenska Handelsbanken upgraded to Neutral from Sell at Citi
Recommendations	Nordea Bank price target raised to EUR 9.10 from EUR 8.60 at Deutsche Bank » 14:57 04/13/21 04/13 14:57 04/13/21 14:57 NRDBY Nordea Bank $10.20 / -0.135 (-1.31%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NRDBY Nordea Bank $10.20 / -0.135 (-1.31%) 04/12/21 Barclays Nordea Bank price target raised to EUR 8.80 from EUR 7.80 at Barclays 04/09/21 UBS Nordea Bank price target raised to SEK 96 from SEK 88 at UBS 03/04/21 JPMorgan Nordea Bank price target raised to SEK 100 from SEK 95 at JPMorgan 02/23/21 Berenberg Nordea Bank price target raised to SEK 90 from SEK 78 at Berenberg
Recommendations	DNB ASA price target raised to NOK 194 from NOK 180 at Deutsche Bank » 14:56 04/13/21 04/13 14:56 04/13/21 14:56 DNHBY DNB ASA $21.38 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DNHBY DNB ASA $21.38 / + (+0.00%) 04/12/21 Barclays DNB ASA price target raised to NOK 142 from NOK 135 at Barclays 03/23/21 UBS DNB ASA price target raised to NOK 143 from NOK 137 at UBS 02/22/21 Keefe Bruyette DNB ASA upgraded to Market Perform from Underperform at Keefe Bruyette 02/17/21 Credit Suisse DNB ASA downgraded to Neutral from Outperform at Credit Suisse
Recommendations	Danske Bank price target raised to DKK 127 from DKK 120 at Deutsche Bank » 14:55 04/13/21 04/13 14:55 04/13/21 14:55 DNKEY Danske Bank $9.93 / +0.09 (+0.91%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DNKEY Danske Bank $9.93 / +0.09 (+0.91%) 04/12/21 Barclays Danske Bank price target raised to DKK 125 from DKK 114 at Barclays 04/12/21 UBS Danske Bank price target raised to DKK 150 from DKK 143 at UBS 02/09/21 Barclays Danske Bank price target raised to DKK 114 from DKK 105 at Barclays 02/08/21 Deutsche Bank Danske Bank price target raised to DKK 120 from DKK 115 at Deutsche Bank
Recommendations	ArcelorMittal price target raised to EUR 30 from EUR 24 at Deutsche Bank » 14:55 04/13/21 04/13 14:55 04/13/21 14:55 MT ArcelorMittal $28.88 / -0.065 (-0.22%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Options MT ArcelorMittal $28.88 / -0.065 (-0.22%) 04/08/21 Infosys announces collaboration with ArcelorMittal 04/01/21 Societe Generale increases shareholding in ArcelorMittal 03/17/21 Air Liquide, ArcelorMittal sign MOU to contribute to decarbonization of Dunkirk 02/11/21 ArcelorMittal CEO to become executive chairman, Aditya Mittal to succeed MT ArcelorMittal $28.88 / -0.065 (-0.22%) 07:06 Today Deutsche Bank ArcelorMittal price target raised to $36 from $30 at Deutsche Bank 04/12/21 UBS ArcelorMittal price target raised to EUR 30 from EUR 25 at UBS 04/09/21 Morgan Stanley ArcelorMittal price target raised to EUR 28.50 from EUR 28 at Morgan Stanley 03/24/21 Morgan Stanley ArcelorMittal price target raised to EUR 28 from EUR 24 at Morgan Stanley MT ArcelorMittal $28.88 / -0.065 (-0.22%) 11/05/20 ArcelorMittal reports Q3 EPS (21c), two estimates (17c) 12 May MT ArcelorMittal $28.88 / -0.065 (-0.22%) 03/24/21 Steel complex lobbies Biden administration on Trump tariffs, Bloomberg says MT ArcelorMittal $28.88 / -0.065 (-0.22%) 04/09/21 Unusually active option classes on open April 9th 04/08/21 Unusually active option classes on open April 8th 04/07/21 ArcelorMittal call volume above normal and directionally bullish 03/31/21 ArcelorMittal call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

Today at 15:15

Fed Reserve Bank President Delivers Closing Remarks Government Event

Virtual Event
CHNG
Today at 15:30

Change Healthcare Inc. Firm Sponsored Meetings
ALL ...
Today at 15:30

Propery & Casualty Insurance/Consumer Industry Meetings
Today at 16:00

Closed Board Meeting Government Event

Virtual Meeting
FANG
Today at 16:00

Diamondback Energy - FANG Conference Calls
PCYO
Today at 16:30

Pure Cycle - PCYO Conference Calls
AVO
Today at 16:30

Mission Produce, Inc. Firm Sponsored Meetings
LKFN
Today at 16:30

Lakeland Financial Corporation Firm Sponsored Meetings
XELB
Today at 17:00

Xcel Brands - XELB Conference Calls
KRUS
Today at 17:00

Kura Sushi - KRUS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $ 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Soliton reports Q4 EPS (22c), consensus (23c)

TODAY'S FREE FLY STORIES

Get Full Fly Access